SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-187279
Filing Date
2020-07-06
Accepted
2020-07-06 06:32:52
Documents
6
Period of Report
2020-07-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d939163d8k.htm 8-K 28949
2 EX-99.1 d939163dex991.htm EX-99.1 61416
3 EX-99.2 d939163dex992.htm EX-99.2 415767
4 GRAPHIC g939163g12i79.jpg GRAPHIC 155566
5 GRAPHIC g939163g28p24.jpg GRAPHIC 146270
6 GRAPHIC g939163g34b40.jpg GRAPHIC 123226
  Complete submission text file 0001193125-20-187279.txt   1093376
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 201012112
SIC: 2836 Biological Products, (No Diagnostic Substances)